alexa Gastrografin|OMICS International|Clinical Trials

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


Gastrografin was the oral contrast medium used for the Gastrografin treatment group’s patients. It is a palatable lemonflavored water-soluble iodinated radiopaque contrast medium. Each mL contained 660 mg diatrizoate meglumine and 100 mg diatrizoate sodium, with a pH adjusted to 6.0 – 7.6 with sodium hydroxide. It also contained 367 mg of organically bound iodine per mL, an essential constituent given its relatively high atomic weight making it sufficiently radio-dense for radiographic contrast with surrounding tissues
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on December, 2020